IISc. researchers contributed to the development of a mathematical model for predicting COVID-19 vaccination efficacy

IISC

Researchers from India’s Indian Institute of Science (IISc.) and Australia’s Queensland Brain Institute (QBI) have developed a mathematical model that predicts how COVID-19 vaccination antibodies confer protection against symptomatic illnesses. Nature Computational Science published the … Read more

The DCGI has approved CORBEVAX, a product produced by Biological E Limited, for Emergency Use Authorization (EUA) in the 12-18-year-old age group

Vaccine, CORBEVAX

CORBEVAX, Biological E Limited’s first indigenously designed Receptor Binding Domain (RBD) protein subunit vaccine for COVID-19, has acquired Emergency Use Authorization from the Drug Controller General of India (DCGI) for the 12-18 year age range. … Read more